Oramed Pharmaceuticals Inc. - Significant Ownership

Signature - Title
/s/ Avraham Gabay - Avraham Gabay, Chief Financial Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Oramed Pharmaceuticals Inc..

Significant Ownership of Oramed Pharmaceuticals Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DRTS Alpha Tau Medical Ltd. Ordinary shares, no par value 19.99% $36M 14.1M Oramed Pharmaceuticals Inc. Apr 24, 2025
SCLX Scilex Holding Co Common Stock, par value $0.0001 per share 9.9% $16.4M $1.36M 833K +9.05% Oramed Pharmaceuticals Inc. Sep 30, 2025
SCLX Scilex Holding Company Common Stock par value $0.0001 per share 9.9% $147K -$2.95M 733K -95.3% Oramed Pharmaceuticals Inc. Mar 31, 2025

Schedules 13D/G Reported by Oramed Pharmaceuticals Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.